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Medication non-adherence is a major public health problem that has been termed
an ‘invisible epidemic.’ Non-adherence is not only associated with negative clinical
consequences but can also result in substantial healthcare costs. Up to now, effective
adherence interventions are scarce and a more comprehensive model of adherence
determinants is required to target the determinants for not taking the medication
as prescribed. Current approaches only included explicit attitudes such as self-
reported evaluations of medication as determinants, neglecting the role of associative
processes that shape implicit attitudes. Implicit processes can predict daily behavior
more accurately than explicit attitudes. Our aim is to assess explicit and implicit
attitudes toward medication and explore the relation with beliefs, adherence and
clinical (laboratory) outcomes in chronically ill patients. Fifty two Rheumatic Arthritis
(RA) patients’ attitudes toward Methotrexate (MTX) were explicitly (self-reported) and
implicitly (Single-Category Implicit Association Test) assessed and related to the Beliefs
about Medicine Questionnaire, the Compliance Questionnaire on Rheumatology and
laboratory parameters [Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein
(CRP)]. Results show that explicit attitudes were positive and health-related. Implicit
attitudes were, however, negative and sickness-related. Half of the patients displayed
explicitly positive but implicitly negative attitudes. Explicit attitudes were positively related
to ESR. A positive relationship between implicit attitudes and disease duration was
observed. In this study, we have obtained evidence suggesting that the measurement
of implicit attitudes and associations provides different information than explicit, self-
reported attitudes toward medication. Since patients’ implicit attitudes deviated from
explicit attitudes, we can conclude that the relationship between implicit attitudes and
medication adherence is worthwhile to be further explored. With this information we
can improve our understanding of the subconscious, automatic processes underlying
adherence and we can develop interventions that target these implicit attitudes.
Keywords: medication adherence, implicit attitudes toward medication, rheumatoid arthritis, disease-modifying
anti rheumatic drugs (DMARDs)
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INTRODUCTION
Non-adherence to pharmacotherapy ranges from 13 to 93%, with
an average rate of 40% (Sabaté, 2003). Despite the strong relation
between appropriate use of medication and health outcomes,
non-adherence remains a significant problem in chronically ill
patients (Neame and Hammond, 2005; Treharne et al., 2005).
Knowledge of determinants associated with medication non-
adherence should help researchers and health care providers to
understand why patients are non-adherent. With this knowledge,
interventions to improve adherence can be developed. These
determinants are commonly studied using self-reports based
on suggestions from cognitive expectancy-value health behavior
models such as the Health Belief Model (Becker, 1974), The
Common Sense Model of Self-Regulation (Leventhal et al.,
2003) and the Theory of Planned Behavior (Ajzen, 1991).
These theories addressing attitude-to-behavior processes share
the assumption that behavior is often driven by deliberate
(conscious) processes such as explicit (self-reported) beliefs
or attitudes. Potentially, one reason why these models fail to
successfully explain adherence (Brandes and Mullan, 2014; Rich
et al., 2015) is that behavior (such as taking medication) is also
influenced by unconscious processes (e.g., implicit determinants)
which cannot be tapped by self-report. This project transcends
these traditional models of health behavior change by focusing
on implicit determinants of medication adherence.
According to the Model of Dual Attitudes (MDA) implicit
attitudes guide behavior that people do not monitor consciously
whereas explicit attitudes predict behavior that is more conscious
(e.g., planned) (Wilson et al., 2000). When the motivation is
high, and/or someone has the attention or opportunities to
deliberately think about the behavior, conscious processes such
as explicit (self-reported) attitudes determine behavior (Gibson,
2008). In the case of a daily behavior, such as medication
adherence, associative (unconscious) processes often take over
(Bargh and Chartrand, 1999). Especially when the motivation
is low, or when the behavior is habitual, one is more likely
to rely on these associative (unconscious) processes (Friese
et al., 2006). Nonetheless, traditional theoretical models of health
behavior change do not take these unconscious processes into
account.
Moreover, as discussed earlier, explicit beliefs, attitudes about
medication, and motivation (e.g., intentions) are often assessed
using self-reports. Self-reported attitudes and behavior are
susceptible to the limits of the patient’s self-knowledge and
the tendency to provide socially desirable answers (Urquhart
and Vrijens, 2005; Sluijs et al., 2006). In other words, studies
relying on questionnaires may have a tendency to err on the
optimistic side when it comes to attitudes toward medication
adherence. Because of that, the adequacy of self-reports in
capturing a complete picture of patients’ medication attitudes
can be questioned, suggesting the need for new innovative
approaches to measure patients’ determinants (Rüsch et al.,
2009).
Thus, attitudes are shaped by two types of evaluative
processes: deliberate (conscious) and associative (unconscious)
processes (Gawronski and Bodenhausen, 2006). When assessing
explicit attitudes, the patient deliberately evaluates and
reports how positive (s)he is about the medication (i.e.,
good or bad) (Gawronski and Bodenhausen, 2006). Such
self-reports are restricted to the limits of awareness and
susceptible to response biases. Oppositely, implicit attitudes
are automatically activated and occur outside the patient’s
conscious awareness and control. A reaction-time task such
as the Single Implicit Association Test (Greenwald et al.,
1998) is able to measure automatic (implicit) associations
between two concepts (i.e., such as the association of taking
medication with being sick) which are indicators of patients’
implicit attitudes (Rüsch et al., 2009). For example, patients
might know that medication prevents their disease from
getting worse and report being positive about it (positive
explicit attitude), but the act of taking medication might
also remind the patient that (s)he is ill (negative implicit
attitude). Patients have less or no insight into these associative
processes (Nisbett and Wilson, 1977; Wilson and Brekke,
1994). Emerging evidence indicates that implicit attitudes
explain a unique part of behavior that cannot be explained
by explicit attitudes and that implicit attitudes can predict
specific kinds of daily behavior more accurately than explicit
attitudes (Dovidio et al., 2002; Galdi et al., 2008; Sheeran et al.,
2013).
Currently, the role of implicit determinants in researching
adherence has been neglected. Therefore, an aspect of non-
adherence remains unexplained (Sheeran et al., 2013). Our aim
is to assess both explicit and implicit attitudes and associations
toward medication and explore their relation to self-reported
beliefs, adherence and clinical outcomes.
MATERIALS AND METHODS
Sample
Consecutive patients (>18 years old) with Rheumatic Arthritis
(RA), using oral Methotrexate (MTX) who had sufficient
knowledge of the Dutch language were recruited between
May and July 2014 at a specialized RA hospital. They were
approached when collecting their medication refill in the
outpatient pharmacy. If patients agreed with participation and
met these criteria, informed consent was obtained. The study
was approved by the institutional review board of the research
institute (number 2014-CW-33).
Treatment Protocol
After signing informed consent, patients performed a
computerized task, consisting of the implicit measures of
medication attitudes and associations. Next, they filled out
a questionnaire which assessed their demographics (i.e., age,
educational level), years of diagnosis, explicit attitudes and
associations. Clinical outcomes, co-morbidity and co-medication
were obtained from patients’ medical file. This procedure was
designed to avoid contamination between tasks. To avoid primed
responses, respondents received little information; they were
debriefed afterward.
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Measurements
Patients’ Attitudes, Associations and Beliefs
To measure patients’ implicit attitudes and associations,
the Single Category Implicit-Association Test (SC-IAT)
was used, which is a well-established and valid measure of
implicit associations (Karpinski and Steinman, 2006). This is
a computer-based task, designed to assess which associations
are related to a certain concept in memory. The strength
of an association is inferred from the time it takes them
to categorize medication stimuli with positive/negative
stimuli. So the strength of an association (i.e., whether
patients associate taking medication with being sick or
becoming healthy) depends on the length of time it takes
them to press “A” or “L.” If a patient takes two seconds to
categorize medication with the word “positive” and it takes
him or her one second to categorize the medication with
the word “negative” then one could say that the patient
has a stronger negative association with the medication.
Patients’ scores on two SC-IATs (positive-negative attitudes
and health-sickness associations) were calculated by
subtracting the log-transformed response times on the
positive categorization block (e.g., medicine-positive or
medicine-health) from those of the negative categorization
block (e.g., medicine-negative or medicine-sickness). This
resulted in difference scores, indicating the relative difference
in categorization speed on the different blocks. Scores greater
than zero indicate that the patients were relatively faster
on positive (health-related) than negative (sickness-related)
categorization blocks, which is an indication that their
implicit associations are positive (health-related). Scores
below zero reflect a reversed response time pattern which
indicates relatively negative (sickness-related) associations
(see Box 1).
Patients’ explicit medication attitude toward MTX was
measured using an 8 items 5-point bipolar evaluative
adjective scale (α = 0.91). The 8 items that were used
to measure patients’ attitude toward medication were for
example ‘beneficial-harmful,’ ‘positive-negative,’ and ‘pleasant-
unpleasant.’ An average score was calculated resulting in
a scale ranging from 1 to 5. Patients’ explicit medication
associations with either health or sickness were assessed with
a 13 items 5-point bipolar evaluative adjective scale (Ajzen,
1991) (α = 0.936). The items that were used to measure
patients’ medication associations were ‘healthy-sickness,’
‘energetic-tired,’ ‘strong-limp’ etc. An average score was
calculated resulting in a scale ranging from 1 to 5. Higher
scores indicated more positive attitudes and health-related
associations.
The beliefs about medicines questionnaire (BMQ-specific) was
used to assess patients’ explicit beliefs toward medication (Horne
et al., 1999). It measures beliefs about the necessity of taking their
medication (α = 0.87) and patients’ concerns about taking their
medication (α = 0.52). The patients were able to indicate their
level of agreement on a 5-point Likert scale ranging from ‘strongly
disagree’ (1) to ’strongly agree’ (5). The scores on each scale were
summed. A necessity-concerns differential (NCD) was calculated
by subtracting the concerns score from the necessity score (Horne
and Weinman, 1999; Clifford et al., 2008; Menckeberg et al.,
2008).
Clinical (Laboratory) Outcomes
Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein
(CRP) values were retrieved from patient’s medical file.
Self-Reported Adherence
Adherence was measured with a 19-item validated medication
adherence scale (Compliance Questionnaire on Rheumatology,
α = 0.87), six items were stated negatively and were therefore
recoded to yield a positive score. The continuous CQR score was
calculated by multiplying the patients’ responses by weight (de
Klerk et al., 2003).
Data Analysis
Descriptive statistics were used to describe the sample and the
attitude scores. For the implicit attitudes, 0 was considered
midpoint and 3 as midpoint for the explicit attitudes. For
the SC-IATs, response times for incorrect responses were
recorded as missing values (3%), as well as latencies faster
than 500 ms or slower than 5000 ms. The remaining response
latencies were log-transformed to account for their skewed
distribution. For sake of interpretation the untransformed
latencies will be reported (Greenwald et al., 1998). One-
sample t-tests were used to determine if the attitude scores
differed from the midpoint. Because of the explorative character
of this study, Pearson’s correlations were used to relate the
patients’ explicit and implicit attitudes, associations, beliefs,
adherence, clinical outcomes and demographics. Correlations
were considered significant if p< 0.05 and marginally significant
if p< 0.1.
BOX 1 | Main procedure of the two Single Category Implicit-Association Tests (SC-IAT).
Participants were instructed to categorize positive stimuli by pressing the L key of the keyboard with their right hand and negative stimuli by pressing the A key of
the keyboard with their left hand. Items included words (N = 10) and pictures (N = 10). Positive words included, for example, ‘nice’ and ‘happy’ and negative words
included ‘stupid’ and ‘sad.’ Pictures included positive illustrations such as a laughing baby or thumbs up and negative illustrations included a crying baby or an
illustration of thumbs down. After completing this practice block of trials, the patients were asked to categorize medication stimuli in addition to the previous stimuli.
Medication stimuli consisted of pictures of people taking pills, pill boxes and the actual MTX pillbox. Blocks occurred in counterbalanced order, with half of the patients
first categorizing medicine items on the same key as positive items (and next making a reversed medicine-negative categorization), and the other half first categorizing
medicine items on the same key as negative items. Next, the patients performed a similar task to measure health versus sickness-related associations. The health-
related stimuli included words (N = 10) and pictures (N = 10). The stimuli included health-related words such as ‘vitality’ and ‘energetic’ and sickness-related words
such as ‘drained’ and ‘tired.’ Health-related pictures included a fit woman and a little girl eating healthy snacks, and the sickness-related pictures consisted of a sick
woman and a little girl with a thermometer in her mouth.
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TABLE 1 | Patient characteristics (N = 52).
Characteristics N = 52 %
Gender
Male 25 48.1
Age M (SD) 58.3 (15.8)
Diagnosed in years M (SD) 11.8 (12.7)
Educational level Low 20 42.6%
Moderate 11 23.4%
High 16 54.0%
Co-morbidity1 1 18
2 12
>2 18
Co-medication2 1 1
2 7
3 1
4 10
>4 33
1Presence of one or more additional diseases co-occurring with RA. 2Number of
co-medication used by the patient in addition to MTX.
RESULTS
Patients’ Characteristics
Fifty-eight consenting patients with RA using oral MTX
participated. Data of 6 patients (10.3%) were removed because
they were aged below 18 years (n = 1), had not finished the
questionnaire (n = 2) or performed the IAT test incorrectly
(n = 3). The final sample consisted of 52 patients who were
on average 58.3 years old (SD = 15.8), were moderately
to highly educated (77.4%) and 48% was male. The average
duration of RA since diagnosis was 11.8 years (SD = 12.7) (see
Table 1).
Patients’ Explicit and Implicit Attitudes
and Associations
Explicitly, the patients reported positive attitudes and health-
related associations with their medication, as is indicated by
attitude scores above the midpoint of 3 on the 5-point scales
(M = 3.7, SD = 0.9; M = 3.6, SD = 0.8, resp.). Or in other
words, patients reported to be positive about their medication
and associated taking medication with being healthy. In contrast,
implicit attitudes toward medication were generally negative
and their associations sickness-related (M = −59, SD = 286;
M = −68, SD = 141 resp.). This indicated that, when measured
implicitly, patients were negative about their medication and
associated their medication with being sick. These implicit
attitudes scores were significantly different from 0 [t(51)–2.12,
p = 0.039 resp. t(51)–4.04, p < 0.001]. A zero score on
the IAT indicates that the implicit attitude toward medication
was neither positive nor negative. In this case, patients were
implicitly significantly negative about their medication (with
zero as reference point). Patients explicit and implicit attitudes
were not correlated (r = 0.08, p = 0.59), nor were the patients’
explicit and implicit associations (r = −0.13, p = 0.35). This
indicates that these two types of measures tap into different
TABLE 2 | Number of patients with congruent and incongruent implicit and
explicit attitudes.
Negative
implicit
attitude
Positive
implicit
attitude
Implicit
sickness
associations
Implicit
health
associations
Negative explicit
attitude
n = 2 n = 3 n = 4 n = 1
Positive explicit
attitude
n = 32 n = 11 n = 28 n = 15
Explicit sickness
associations
n = 3 n = 2 n = 3 n = 2
Explicit health
associations
n = 31 n = 12 n = 29 n = 14
processes (an explicit and implicit process). Explicit attitudes
and associations were related (r = 0.77, p < 0.001), so were
implicit attitudes and associations (r = 0.35, p = 0.01). Thus,
patients who associated their medication with being healthy
(respectively explicitly or implicitly) held more (respectively
explicit or implicit) positive attitudes toward their medication.
Notably, more than half of the patients displayed implicit
attitudes that were incongruent with their self-reported explicit
attitudes (see Table 2).
Exploratory Findings
Further inspection of the data showed no significant correlations
between self-reported adherence and explicit attitudes (r= 0.035,
p = 0.82), implicit attitudes (r = 0.059, p = 0.70), or implicit
associations (r = −0.02, p = 0.89). This means that there was
no correlation between adherence, patient’s explicit attitudes or
implicit attitudes. There was a trend effect (p = 0.07) with a
small to medium effect size (r = 0.28) that explicit associations
correlated with self-reported adherence. Thus, the more the
patients self-reportedly associated their medication with health,
the more adherent they reported to be.
Explicit attitudes and associations positively correlated with
beliefs about medicines (r = 0.35, p = 0.01 resp. r = 0.33,
p = 0.02) indicating that the more positive patients explicitly
are, the more they report to perceive that their medication
outweighed patients’ concerns about medication. Moreover,
explicit attitudes and associations were significantly related
to age (r = 0.41, p = 0.003 resp. r = 0.39, p < 0.001)
indicating that older patients were explicitly more positive
about their medication. Concerning patients’ clinical outcomes,
a positive significant correlation between explicit attitudes and
associations and patients’ ESR was found (r = 0.41, p = 0.013
resp. r = 0.35, p = 0.03). In other words, patients with a
higher inflammatory activity were more positive about their
medication. Implicit attitudes correlated marginally with explicit
beliefs (r = 0.26, p = 0.08) indicating that patients with
more positive implicit attitudes report to perceive that their
medication outweighed patients’ concerns about medication.
Lastly, implicit associations were marginally significantly related
to the years since diagnosis (r = 0.27, p = 0.05) indicating the
longer the patients were diagnosed, the more their medication
was implicitly associated with health (versus sickness; see
Table 3).
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DISCUSSION
The aim of this study was to assess RA patients’ explicit and
implicit medication attitudes and associations, and to explore
their relation to self-reported beliefs, medication adherence, and
clinical outcomes. Explicitly, patients reported positive attitudes
and health-related associations with their medication. Implicit
medication attitudes and associations were, however, generally
negative and sickness-related. Patients’ implicit and explicit
attitudes did not correlate, which indicates a simultaneous but
conflicting activation of two different processes (Nosek, 2005).
Based on these results, we argue that only addressing explicit
attitudes when improving medication adherence might overlook
patients who have conflicting attitudes; patients who are explicitly
positive but implicitly negative regarding their medication, which
constitutes no less than 50 percent of the current patient sample.
Patients who show this pattern of incongruent responses are
either unaware of their implicit negativity or are subject to
response biases, and are therefore unable to report it explicitly
(Dovidio and Fazio, 1992). In a follow-up study with a greater
number of patients (higher power) it would be interesting to
structurally compare groups (i.e., congruent and incongruent
explicit and implicit attitudes) with respect to their behavior
and clinical outcomes. With this information, interventions can
be developed that target patients’ congruent or incongruent
medication attitudes.
Exploratory analyses revealed that in line with previous
research (Rüsch et al., 2009), patients’ explicit, but not
implicit, associations toward medication are related to self-
reported medication adherence. When patients are motivated
to deliberately think about their medication intake, which is
the case when filling out a questionnaire about medication
adherence, deliberate processes such as explicit attitudes take
over (Gibson, 2008). Consequently, explicit attitudes assessed
via self-report correlated more strongly with self-reported
behavior. However, individuals often do not know what
influences their behavior. Implicit attitudes have been shown
to correlate more strongly with actual (versus self-reported)
behavior (Dovidio et al., 2002; Galdi et al., 2008; Gawronski
and Payne, 2010). In light of the unique effects of implicit
attitudes’ on objectively measured (versus self-reported) behavior
(Dovidio et al., 2002; Galdi et al., 2008) the results of the
present study – predominantly negative implicit attitudes toward
medication – might explain the low actual adherence rates
found in previous studies (Hetland et al., 2010; Van den Bemt
et al., 2012). That is, even though patients often report to be
positive about their medication, they might not fully adhere
to their treatment, because they inadvertently have negative
and sick-related associations with the medication and behave
accordingly without being conscious about it. It might be
worthwhile to explore the relation between implicit attitudes
and adherence which can be measured more objectively with
for example Electronic Monitoring devices (Van den Bemt et al.,
2012).
Patients with a lower inflammatory activity were explicitly
more negative about their medication. Older patients were
explicitly more positive about their medication. Our results
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also show a positive relationship between implicit attitudes and
disease duration, indicating that the longer the patients were
diagnosed, the more they implicitly associated their medication
with being healthy. This result can be explained by the Patient
Health Engagement Model (PHE). According to this model,
patients may be differently engaged in their health. These
differences can be explained by their emotional, cognitive or
behavioral mindset. For example, when patients are newly
diagnosed, they are not able to fully participate in their health
care because of their concerns about their health. However, the
longer patients are diagnosed, the more knowledge they gain, and
the more emotionally stabilized they are. Consequently, they are
more confident that they can manage their disease and might
implicitly relate their medication with being healthy (Graffigna
et al., 2015). Furthermore, both patients’ explicit and implicit
attitudes were positively correlated with patients’ explicit beliefs
about medication. It might be that both implicit and explicit
attitudes seem to explain some part of patients’ self-reported
beliefs and should be further explored in new research.
A limitation of this study is the small sample size and
future research should replicate our findings with a larger
sample. Another limitation of this study is that we did not
use an objective measure for actual (rather than self-reported)
adherence. As previous research suggests that measures designed
to capture implicit attitudes might predict actual adherence
behavior more accurately than explicit self-reported behavior
(Blair et al., 2011), future research should explore the predictive
value of implicit attitudes for patients’ actual medication intake
behavior. With more information about the predictive value
of implicit determinants of actual behavior, interventions that
improve patients’ implicit attitudes might lead to more functional
(adherent) behavior.
The aim of our study was to assess both explicit and implicit
attitudes and associations toward medication and we did not
explore which factors these implicit attitudes shape. A prominent
view of the origins of implicit attitudes holds that they are often
a result of repeated/past experiences and developed through
socialization processes (Crano and Prislin, 2011). Empirical
evidence supporting this view comes from research in other
settings than medication adherence. Further research is needed
to explore what shapes patients’ implicit attitudes toward their
medication.
Up to now, when understanding and predicting medication
(non-)adherence, researchers have mainly relied on theories such
as the Health Belief Model (Horne and Weinman, 1998), The
Common Sense Model of Self-Regulation (Leventhal et al., 2003)
and the Theory of Planned Behavior (Ajzen, 1991). These theories
are based on the assumption that people must be motivated to
take their medication and that patients are active, self-regulating
problem solvers. However, these theories only partly explain non-
adherence. For example, recent meta-analyses on the predictive
value of the Theory of Planned Behavior and the Common
Sense Model of Self-Regulation show that these models have little
predictive value in explaining medication adherence (Brandes
and Mullan, 2014; Rich et al., 2015). Moreover, these theories
have been criticized for their focus on rational reasoning (i.e.,
planned behavior) and the exclusion of associative (unconscious)
processes (Sniehotta et al., 2014). By including patients’ implicit
attitudes and associations with their medication in addition to
the predominantly tested explicit attitudes and associations, we
aimed to pinpoint potentially relevant and influential implicit
determinants of the patients’ adherence behavior to understand
the reported discrepancy between reported attitudes and actual
adherence. We have obtained evidence suggesting that the
measurement of implicit attitudes and associations provides
different information than explicit, self-reported attitudes toward
medication. Giving the above, we can conclude that the
relationship between implicit attitudes and medication adherence
is worth being further explored which may lead to more effective
interventions targeted at implicit or incongruent implicit versus
explicit attitudes.
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